NCT05002946View on ClinicalTrials.gov

Pharmacokinetics of SP-104

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 11, 2022

Primary Completion Date

April 24, 2022

Study Completion Date

April 24, 2022

Conditions
Healthy
Interventions
DRUG

SP-104

single oral dose

DRUG

Naltrexone Hydrochloride 50Mg Oral Tablet

single oral dose

Trial Locations (1)

8011

Christchurch Clinical Studies Trust (NZCR), Christchurch

All Listed Sponsors
lead

Scilex Pharmaceuticals, Inc.

INDUSTRY

NCT05002946 - Pharmacokinetics of SP-104 | Biotech Hunter | Biotech Hunter